Loomis, Sayles & Company’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02B | Buy |
|
|||||
|
2025
Q1 | $1.04B | Buy |
|
|||||
|
2024
Q4 | $1.12B | Buy |
|
|||||
|
2024
Q3 | $1.24B | Sell |
|
|||||
|
2024
Q2 | $1.28B | Buy |
|
|||||
|
2024
Q1 | $1.16B | Sell |
|
|||||
|
2023
Q4 | $1.07B | Sell |
|
|||||
|
2023
Q3 | $1.01B | Sell |
|
|||||
|
2023
Q2 | $918M | Sell |
|
|||||
|
2023
Q1 | $1.08B | Sell |
|
|||||
|
2022
Q4 | $965M | Sell |
|
|||||
|
2022
Q3 | $1.18B | Sell |
|
|||||
|
2022
Q2 | $1.04B | Sell |
|
|||||
|
2022
Q1 | $1.78B | Sell |
|
|||||
|
2021
Q4 | $1.66B | Sell |
|
|||||
|
2021
Q3 | $1.67B | Buy |
|
|||||
|
2021
Q2 | $1.54B | Sell |
|
|||||
|
2021
Q1 | $1.36B | Sell |
|
|||||
|
2020
Q4 | $1.43B | Sell |
|
|||||
|
2020
Q3 | $1.78B | Sell |
|
|||||
|
2020
Q2 | $2.03B | Sell |
|
|||||
|
2020
Q1 | $1.71B | Sell |
|
|||||
|
2019
Q4 | $1.39B | Buy |
|
|||||
|
2019
Q3 | $996M | Buy |
|
|||||
|
2019
Q2 | $1.03B | Buy |
|
|||||
|
2019
Q1 | $1.3B | Buy |
|
|||||
|
2018
Q4 | $1.18B | Sell |
|
|||||
|
2018
Q3 | $1.35B | Buy |
|
|||||
|
2018
Q2 | $1.14B | Buy |
|
|||||
|
2018
Q1 | $971M | Buy |
|
|||||
|
2017
Q4 | $790M | Buy |
|
|||||
|
2017
Q3 | $836M | Buy |
|
|||||
|
2017
Q2 | $895M | Buy |
|
|||||
|
2017
Q1 | $668M | Buy |
|
|||||
|
2016
Q4 | $630M | Buy |
|
|||||
|
2016
Q3 | $462M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $2.43M | Buy |
|
|||||
|
2013
Q3 | $2.44M | Buy |
|
|||||
|
2013
Q2 | $1.66K | Buy |
|